AUBAGIO for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where AUBAGIO was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for AUBAGIO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Alopecia | 259 | 24.0% | 1 | 27 |
| Diarrhoea | 172 | 16.0% | 2 | 25 |
| Nausea | 127 | 11.8% | 0 | 26 |
| Fatigue | 97 | 9.0% | 3 | 25 |
| Drug dose omission | 93 | 8.6% | 2 | 32 |
| Paraesthesia | 86 | 8.0% | 1 | 18 |
| Hypoaesthesia | 80 | 7.4% | 2 | 17 |
| Headache | 79 | 7.3% | 1 | 20 |
| Multiple sclerosis relapse | 76 | 7.1% | 3 | 31 |
| Pain | 52 | 4.8% | 0 | 14 |
| Dizziness | 48 | 4.5% | 1 | 11 |
| Rash | 48 | 4.5% | 0 | 6 |
| Fall | 47 | 4.4% | 2 | 26 |
| Gait disturbance | 46 | 4.3% | 1 | 15 |
| Asthenia | 41 | 3.8% | 2 | 20 |
Other Indications for AUBAGIO
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)